MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Celldex Therapeutics Operativer Cashflow 2011-2026 | CLDX
Operativer Cashflow Jährlich Celldex Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -158 M | -107 M | -104 M | -60.9 M | -40.4 M | -46.4 M | -75.2 M | -99.9 M | -113 M | -98.9 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -40.4 M | -158 M | -90.4 M |
Operativer Cashflow Vierteljährlich Celldex Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -54.4 M | - | - | - | -40.6 M | - | - | - | -28.6 M | - | -82 M | -46.8 M | -24.5 M | - | -46.4 M | -30 M | -18.1 M | - | -35.2 M | -23.3 M | -12.1 M | - | -35.4 M | -24.3 M | -13.2 M | - | -59.8 M | -45.4 M | -28 M | - | -80.4 M | -56 M | -35.3 M | - | -92.7 M | -68.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -12.1 M | -92.7 M | -42.7 M |
Operativer Cashflow anderer Aktien in der Pharmaeinzelhändler
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Biogen
BIIB
|
2.88 B | $ 172.65 | 0.62 % | $ 25.1 B |  USA |
 |
MorphoSys AG
MOR
|
-481 M | - | 2.43 % | $ 254 M |  Germany |
 |
Adagene
ADAG
|
-29.7 M | $ 2.38 | -4.22 % | $ 134 M |  China |
 |
Acorda Therapeutics
ACOR
|
-14 M | - | -24.86 % | $ 820 K | USA |
 |
BioNTech SE
BNTX
|
890 M | $ 117.22 | 1.07 % | $ 27.2 B | Germany |
 |
Aptorum Group Limited
APM
|
-1.19 M | $ 0.98 | 1.35 % | $ 5.34 M | China |
 |
Alterity Therapeutics Limited
ATHE
|
-12.3 M | $ 3.62 | 1.91 % | $ 8.71 B |  Australia |
 |
Biophytis SA
BPTS
|
-23.8 M | - | -13.47 % | $ 169 M |  France |
 |
Catalyst Biosciences
CBIO
|
25.9 M | $ 12.1 | -5.47 % | $ 797 M | USA |
 |
Midatech Pharma plc
MTP
|
-6.01 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Akero Therapeutics
AKRO
|
-230 M | - | - | $ 3.67 B | USA |
 |
BioXcel Therapeutics
BTAI
|
-72 M | $ 1.78 | -2.47 % | $ 4.51 M | USA |
 |
BioLineRx Ltd.
BLRX
|
-23.6 M | $ 3.05 | -1.77 % | $ 908 M |  Israel |
 |
Applied Molecular Transport
AMTI
|
-93.9 M | - | - | $ 10.1 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-418 M | $ 232.9 | -1.06 % | $ 5 B |  Danmark |
 |
Burford Capital Limited
BUR
|
181 M | $ 9.73 | -0.21 % | $ 1.57 B | Britain |
 |
ARCA biopharma
ABIO
|
-57.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Cellectis S.A.
CLLS
|
-105 M | $ 4.21 | -4.84 % | $ 116 M | France |
 |
Acasti Pharma
ACST
|
-14.9 M | - | 4.01 % | $ 150 M |  Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
180 M | $ 67.14 | 0.13 % | $ 8.98 B | USA |
 |
Compugen Ltd.
CGEN
|
49.6 M | $ 2.05 | -1.91 % | $ 184 M | Israel |
 |
Can-Fite BioPharma Ltd.
CANF
|
-7.64 M | $ 4.4 | -2.87 % | $ 9.57 B | Israel |
 |
Aeterna Zentaris
AEZS
|
-8.58 M | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-7.8 M | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-157 M | - | - | $ 1.01 B | USA |
 |
Akouos
AKUS
|
-63.7 M | - | 0.23 % | $ 488 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-141 M | - | -15.15 % | $ 60.3 M | Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
213 M | $ 26.56 | 2.45 % | $ 1.29 B | USA |
 |
Coherus BioSciences
CHRS
|
-175 M | $ 2.25 | 9.22 % | $ 212 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
295 M | $ 13.58 | 1.42 % | $ 4.2 B | USA |
 |
AIkido Pharma
AIKI
|
-15.1 M | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
-108 M | - | -0.23 % | $ 916 M | USA |
 |
CureVac N.V.
CVAC
|
-733 M | - | - | $ 867 M | Germany |
 |
Aptose Biosciences
APTO
|
-36 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Acer Therapeutics
ACER
|
-30.3 M | - | 2.71 % | $ 14 M | USA |
 |
Aravive
ARAV
|
-65.1 M | - | -13.39 % | $ 1.45 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-43.8 M | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-67.7 M | - | 4.14 % | $ 49.1 M | USA |
 |
Athira Pharma
ATHA
|
-97.2 M | - | - | $ 269 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-8.56 M | - | -11.43 % | $ 502 K | USA |
 |
AVROBIO
AVRO
|
-63.2 M | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-34.5 M | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-1.94 M | $ 2.75 | 1.84 % | $ 17.3 M | USA |
 |
AstraZeneca PLC
AZN
|
5.96 B | $ 94.2 | 1.34 % | $ 96.9 B | Britain |
 |
Arena Pharmaceuticals
ARNA
|
-452 M | - | -6.81 % | $ 3.04 B | USA |
 |
Brickell Biotech
BBI
|
-4.34 M | - | -5.38 % | $ 6.06 M | USA |